Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DM199 for pregnancy complications
PACTR202404895013782Phase 1Recruiting
- Sponsor
- Stellenbosch University
- Start
- Nov 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, single-arm trial of rinvecalinase alfa in preeclampsia and intrauterine growth restriction (IUGR), sponsored by Stellenbosch University. Started Nov 2024; status: recruiting.
02
Drugs
rinvecalinase alfa
03
Conditions
preeclampsiaintrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on PACTR202404895013782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202404895013782.